Fig. 1From: Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trialFlowchart of the post-corona-virus immune treatment (PoCoVIT) trialBack to article page